Utility of Acellular Allograft Dermis in the Care of Elderly Burn Patients

Because skin thins with advancing age, traditional thickness skin grafts cannot always be obtained in very elderly burn patients without creating a new full-thickness wound at the skin graft donor site. In an attempt to circumvent this problem, acellular allograft dermis (Alloderm, Life Cell Corp.,...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of surgical research 2005-05, Vol.125 (1), p.37-41
Main Author: Gore, Dennis C.
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Alloderm
Biological and medical sciences
Burns
Burns - mortality
Burns - surgery
Female
General aspects
geriatrics
Humans
Length of Stay
Male
Medical sciences
Skin Transplantation
Transplantation, Homologous
trauma
Traumas. Diseases due to physical agents
wound care
Wound Healing
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Because skin thins with advancing age, traditional thickness skin grafts cannot always be obtained in very elderly burn patients without creating a new full-thickness wound at the skin graft donor site. In an attempt to circumvent this problem, acellular allograft dermis (Alloderm, Life Cell Corp., The Woodlands, TX) and thin autograft (depth 0.005 inches) was used in skin grafting 10 elderly burn patients (age 78 year ± 2, TBSA burn 17% ± 2; mean ± SEM) over a 1-year period. The outcome of patients receiving Alloderm was compared retrospectively to a similar group of 18 elderly patients admitted over the prior year, eight of whom underwent operative wound excision and autografting (depth 0.014 inches) without Alloderm. Length of hospital stay was significantly reduced in patients treated with Alloderm compared to the total group of elderly in whom selective use of operative debridement and skin grafting was used. Functional outcome was improved in those patients who underwent skin grafting regardless of operative technique. Donor site healing time was significantly reduced with Alloderm (12 days ± 1 versus 18 days ± 2), while graft take was similar to conventional autografting. Unfortunately, 3-month mortality remained poor regardless of operative skin grafting or technique used. This initial experience suggests that use of Alloderm may allow more elderly burn patients to undergo operative wound closure, thus improving functional outcome and reducing hospitalization. Unfortunately, long-term survival for very elderly burn patients remains poor.
ISSN:0022-4804
1095-8673
DOI:10.1016/j.jss.2004.11.032